|
|||||
|
|
Lactobacillus brevis G‐101 ameliorates colitis in mice by inhibiting NF‐κB,MAPK and AKT pathways and by polarizing M1 macrophages to M2‐like macrophages |
|
| Authors: | S.‐E. Jang S.R. Hyam M.J. Han S.‐Y. Kim B.‐G. Lee D.‐H. Kim |
| Affiliation: | 1. Department of Pharmacy, College of Pharmacy, Kyung Hee University, , Seoul, Korea;2. Department of Food and Nutrition, Kyung Hee University, , Seoul, Korea;3. R&D center, CTOBIO Inc., , Gyeonggi‐do, Korea |
| Abstract: | |
| Keywords: | colitis IL‐10 Lactobacillus brevis G‐101 macrophage polarization NF‐kB |